Home › Compare › KSRBF vs ABBV
KSRBF yields 3.00% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, KSRBF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KSRBF + ABBV for your $10,000?
Kossan Rubber Industries Bhd, an investment holding company, manufactures and sells latex disposable gloves in Malaysia and internationally. It operates through four segments: Technical Rubber Products, Gloves, Cleanroom Products, and Others. The company offers engineered rubber products, including marine dock fenders, high damping rubber bearings, elastomeric bearings, expansion joints, panels and liners, and mechanical pot bearings, as well as floating slab track bearings, lateral bearings, and rubber wedges; EVA products primarily for the shoe industries; and custom extruded products and profiles, such as pressure sensor, solid and sponge, extruded, structural insulation, and insulator profiles for domestic, construction and civil engineering, electrical appliance, industrial, and automotive applications. It also provides molded rubber products for automotive, pipe seals and gaskets, and industrial/general applications; rubber rolls for printing, transferring, laminating, coating, coiling, beading creasing, pressure, slitting, winding, and other applications; and polyurethane (PU) products, such as PU rollers, precision PU articles, and PU tubing sleeves and robs. In addition, it manufactures natural rubber latex and nitrile gloves, as well as rubber latex surgical and procedure gloves for healthcare, specialty, and cleanroom applications under Puresafe, Chemax, and 7th Sense brand names. Further, the company offers cleanroom facemasks, gloves, and wipes; and industrial personal protective equipment. Additionally, it engages in the fabrication and installation of machinery; manufacturing, processing, and trading of chemicals and rubber compounds; and distribution and property holding activities. The company was incorporated in 1979 and is based in Klang, Malaysia.
Full KSRBF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.